DK0720604T3 - Konformationelt låste nukleosidanaloger - Google Patents

Konformationelt låste nukleosidanaloger

Info

Publication number
DK0720604T3
DK0720604T3 DK94929321T DK94929321T DK0720604T3 DK 0720604 T3 DK0720604 T3 DK 0720604T3 DK 94929321 T DK94929321 T DK 94929321T DK 94929321 T DK94929321 T DK 94929321T DK 0720604 T3 DK0720604 T3 DK 0720604T3
Authority
DK
Denmark
Prior art keywords
nucleoside analogs
conformationally locked
cyclopropane
compounds
locked nucleoside
Prior art date
Application number
DK94929321T
Other languages
English (en)
Inventor
Victor E Marquez
Juan B Rodriguez
Marc C Nicklaus
Joseph J Barchi Jr
Maqbool A Siddiqui
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of DK0720604T3 publication Critical patent/DK0720604T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/26Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32Nitrogen atom
    • C07D473/34Nitrogen atom attached in position 6, e.g. adenine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94929321T 1993-09-24 1994-09-23 Konformationelt låste nukleosidanaloger DK0720604T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12679693A 1993-09-24 1993-09-24
PCT/US1994/010794 WO1995008541A1 (en) 1993-09-24 1994-09-23 Conformationally locked nucleoside analogues

Publications (1)

Publication Number Publication Date
DK0720604T3 true DK0720604T3 (da) 1998-07-27

Family

ID=22426712

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94929321T DK0720604T3 (da) 1993-09-24 1994-09-23 Konformationelt låste nukleosidanaloger

Country Status (10)

Country Link
US (2) US5629454A (da)
EP (1) EP0720604B1 (da)
JP (1) JP3481945B2 (da)
AT (1) ATE160340T1 (da)
AU (1) AU677441B2 (da)
DE (1) DE69406943T2 (da)
DK (1) DK0720604T3 (da)
ES (1) ES2111960T3 (da)
GR (1) GR3026166T3 (da)
WO (1) WO1995008541A1 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840728A (en) * 1996-08-07 1998-11-24 United States Of America As Represented By The Department Of Health And Human Services Conformationally locked nucleoside analogs as antiherpetic agents
AU6766496A (en) * 1996-08-07 1998-02-25 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Conformationally locked nucleoside analogs as antiherpetic agents
ATE336492T1 (de) 2000-01-14 2006-09-15 Us Gov Health & Human Serv Methonocarbacycloalkylanaloga von nucleosiden
DE60139875D1 (de) * 2000-07-26 2009-10-22 Us Gov Health & Human Serv 5-substituierte pyrimidinderivate eines konformatiosfestgelegten nukleosidanalogen
US20020187479A1 (en) * 2001-06-12 2002-12-12 Gayle Dace In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
US20030032028A1 (en) * 2001-06-12 2003-02-13 Gayle Dace In vitro capture of nucleic acids via modified oligonucleotides and magnetic beads
JP4457001B2 (ja) * 2002-05-31 2010-04-28 セクレタリー・デパートメント・オブ・アトミック・エナジー ドナー/アクセプター部分が相補鎖上となる標的核酸検出のmet/fretに基づく方法
AU2003260292A1 (en) * 2002-09-11 2004-04-30 Exiqon A/S A population of nucleic acids including a subpopulation of lna oligomers
WO2006091905A1 (en) * 2005-02-25 2006-08-31 Gilead Sciences, Inc. Bicyclo (3.1.0) hexane derivatives as antiviral compounds
US20090221523A1 (en) * 2005-05-25 2009-09-03 Tseng Christopher K North-2'-deoxy-methanocarbathymidines as antiviral agents against poxviruses
EP2507241A1 (en) 2009-12-02 2012-10-10 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Methanocarba adenosine derivatives and dendrimer conjugates thereof
WO2015142910A1 (en) 2014-03-17 2015-09-24 Isis Pharmaceuticals, Inc. Bicyclic carbocyclic nucleosides and oligomeric compounds prepared therefrom
JP6546268B2 (ja) 2014-08-04 2019-07-17 オーバーン・ユニバーシティAuburn University ネプラノシンaの1’,6’−異性体の鏡像体
KR101875997B1 (ko) 2015-05-04 2018-07-06 엔 앤드 엔 파마세우티칼스 인크. 엔-메탄노카르바티미딘을 이용한 대상포진의 치료방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0577558A2 (de) * 1992-07-01 1994-01-05 Ciba-Geigy Ag Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte

Also Published As

Publication number Publication date
AU7842094A (en) 1995-04-10
DE69406943D1 (de) 1998-01-02
ATE160340T1 (de) 1997-12-15
GR3026166T3 (en) 1998-05-29
JP3481945B2 (ja) 2003-12-22
JPH09502986A (ja) 1997-03-25
DE69406943T2 (de) 1998-05-07
EP0720604A1 (en) 1996-07-10
AU677441B2 (en) 1997-04-24
US5629454A (en) 1997-05-13
EP0720604B1 (en) 1997-11-19
US5869666A (en) 1999-02-09
ES2111960T3 (es) 1998-03-16
WO1995008541A1 (en) 1995-03-30

Similar Documents

Publication Publication Date Title
DK0720604T3 (da) Konformationelt låste nukleosidanaloger
PA8483101A1 (es) Compuestos quimicos
EA199800009A1 (ru) Ингибиторы аденозинкиназы, модифицированные по атому с-4′
TR200302313T4 (tr) Antivirütik pirimidin nükleosid analogları
ES2085446T3 (es) Derivados de acido 9-purinil fosfonico.
BR0111531A (pt) Nucleosìdeos de pirido[2,3-d]pirimidina e pirimido[4,5-d]pirimidina
AU4690989A (en) Antiviral cytosine and guanine derivatives
FI932870A0 (fi) 2'-deoxi-2'2'-difluor-(4-substituerad pyrimidin)nukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
IE900275L (en) Antivirals and methods of increasing the antiviral activity¹of azt
CA2054870A1 (en) Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives
DK0482081T3 (da) Antiviralt præparat
DE3854811D1 (de) Anti-HIV Pyrimidin Nucleoside
FI932868A0 (fi) 2'-deoxi-2'2'-difluor(2,6,8-substituerade) purinnukleosider med virus-och cancerhaemmande aktivitet, samt mellanprodukter
CA2172534A1 (en) Conformationally locked nucleoside analogues
KR960701639A (ko) 심기능 회복제(heart function restorative)
GB9506644D0 (en) Preparation of nucleoside analogues
JPS6422853A (en) Nucleoside analog
IT1254519B (it) Associazioni di composti ad attivita' antivirale
WO1993000099A3 (de) Verwendung von pyrimidin- und purinnucleosiden zur prophylaxe und/oder behandlung von durch adenoviren verursachten infektionen
Umnova et al. Role of guanine derivatives in biosynthesis of uridine 5'-monophosphate in Brevibactrerium ammoniagenes
MX9709782A (es) Derivados de aciclovir para aplicacion topica.